4th Gene Therapy for Rare Disorders USA - digital event

The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.

On Day One (February 23) our CEO, Ales Strancar's will present:

4:30 pm EST | 3rd Generation AAV Manufacturing Platform & In-Process Controls